E3 PreliminaryPreliminaryPEM not requiredMechanisticPeer-reviewedMachine draft
Polysaccharide of radix pseudostellariae improves chronic fatigue syndrome induced by poly I:C in mice.
Sheng, Rong, Xu, Xianxiang, Tang, Qin et al. · Evidence-based complementary and alternative medicine : eCAM · 2011 · DOI
Quick Summary
Researchers tested whether a natural plant compound called polysaccharide from Radix Pseudostellariae (PRP) could help mice recover from fatigue-like symptoms. They found that mice given PRP before being exposed to a virus-like trigger showed less fatigue and better recovery of normal immune and stress hormone function compared to untreated mice.
Why It Matters
Understanding how natural compounds modulate immune and neuroendocrine dysfunction may provide insights into potential therapeutic targets in ME/CFS, particularly the role of immune dysregulation and stress hormone abnormalities. This preclinical work could inform future clinical studies of immunomodulating interventions in human patients.
Observed Findings
- Mice exposed to poly I:C showed fatigue symptoms lasting at least 1 week measurable by forced swimming time
- PRP treatment at all doses (100–400 mg/kg) produced dose-dependent reductions in fatigue symptoms
- Poly I:C induced reduced corticosterone levels, which PRP partially restored
- Poly I:C altered T lymphocyte parameters (increased numbers but decreased proliferation); PRP normalized these abnormalities
- PRP restored learning ability and spontaneous activity in treated mice
Inferred Conclusions
- The authors concluded that PRP exerts anti-fatigue effects through dual modulation of neuroendocrine and immune system dysfunction
- They propose that PRP may normalize stress hormone signaling and restore appropriate T lymphocyte function
- The dose-dependent response suggests a pharmacological mechanism rather than a non-specific effect
Remaining Questions
- Does PRP efficacy translate to human patients with ME/CFS, and at what equivalent doses?
- Which specific active components of PRP mediate immune and neuroendocrine effects?
- How does the acute poly I:C model relate to the chronic, multisystem pathophysiology of human ME/CFS, particularly post-exertional malaise?
What This Study Does Not Prove
This animal model study does not prove that PRP will be effective in human ME/CFS patients, as mice and humans differ substantially in metabolism, immune response, and disease complexity. The poly I:C model induces acute fatigue-like symptoms rather than replicating the chronic, post-exertional malaise characteristic of human ME/CFS. Efficacy in mice does not establish safety or efficacy in humans without clinical trials.
Tags
Symptom:Cognitive DysfunctionFatigue
Biomarker:CytokinesBlood Biomarker
Phenotype:Infection-Triggered
Method Flag:PEM Not DefinedWeak Case DefinitionSmall SampleExploratory Only
Metadata
- DOI
- 10.1093/ecam/nep208
- PMID
- 20008077
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →